Risk Factors for Acute Kidney Injury after Congenital Cardiac Surgery in Infants and Children: A Retrospective Observational Study

Adult Male Adolescent Science Risk Assessment Young Adult 03 medical and health sciences Postoperative Complications 0302 clinical medicine Risk Factors Humans Cardiac Surgical Procedures Child Retrospective Studies Cardiopulmonary Bypass Incidence Q R Infant, Newborn Infant Acute Kidney Injury 3. Good health Child, Preschool Medicine Female Research Article
DOI: 10.1371/journal.pone.0166328 Publication Date: 2016-11-10T13:56:56Z
ABSTRACT
Acute kidney injury (AKI) after pediatric cardiac surgery is associated with high morbidity and mortality. Modifiable risk factors for postoperative AKI including perioperative anesthesia-related parameters were assessed. The authors conducted a single-center, retrospective cohort study of 220 patients (aged 10 days to 19 years) who underwent congenital between January December 2012. incidence within 7 postoperatively was determined using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Ninety-two (41.8%) developed 18 (8.2%) required renal replacement therapy first week. Among AKI, 57 (25.9%) KDIGO stage 1, 27 (12.3%) 2, eight (3.6%) 3. RACHS-1 (Risk-Adjusted classification Congenital Heart Surgery) category, transfusion fluid administration as well overload compared without AKI. Multivariable logistic regression analyses longer hospital stay or ICU stay, frequent sternal wound infections. Younger age (<12 months) [odds ratio (OR), 4.01; 95% confidence interval (CI), 1.77-9.06], cardiopulmonary bypass (CPB) time (OR, 2.45; CI, 1.24-4.84), low preoperative hemoglobin 2.40; 1.07-5.40) independent Fluid not significant predictor When variable concentration increase (>3 g/dl) from level on POD1 entered into multivariable analysis, it independently 6.51; 2.23-19.03 no increase). This association adjustment patient demographics, medication history category (hemoglobin >3g/dl vs. increase: adjusted OR, 6.94; 2.33-20.69), regardless different groups cyanotic non-cyanotic heart disease. Prospective trials are evaluate whether correction anemia prevention hemoconcentration may ameliorate in surgery.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (93)